Compare Colgate-Palmolive Company (CL) vs Altria Group Inc (MO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Colgate-Palmolive Company vs Altria Group Inc — how do they compare? Colgate-Palmolive Company trades at $92.43 (market cap $73.59B), while Altria Group Inc trades at $64.54 (market cap $108.58B). The key difference: Altria Group Inc is the larger of the two by market cap, and Altria Group Inc pays the higher dividend (6.52%). Which is the better fit depends on your goals.
| CL | MO | |
|---|---|---|
Market Cap | $73.59B | $108.58B |
Sector | Consumer Staples | Consumer Staples |
52-Week High | $99.14 | $74.92 |
52-Week Low | $74.98 | $54.72 |
Enterprise Value | $80.07B | $130.79B |
Dividend Yield | 2.3% | 6.52% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Colgate-Palmolive (CL) trades at $92.54, down 0.65% on the day, with neutral technical signals and strong fundamentals. The company reported Q2 2026 EPS of $0.99, beating estimates, with 4.9% revenue growth and margin expansion. Recent news highlights director share sales and mixed regional performance, particularly weakness in North America despite global strength.
CL offers stable dividend returns and consistent earnings but faces valuation concerns with a P/E of 36.34 and competitive pressures in key markets. Analyst consensus targets $99.10 with 42% buy ratings, suggesting moderate upside potential balanced against premium valuation and domestic market challenges.
Altria Group (MO) trades at $64.47, down 1.63% today, with a bearish technical signal despite oversold RSI readings near 18-27. The company maintains strong profitability with 39% net income margins and a 6.3% dividend yield, though recent earnings show mixed results with two misses in the last four quarters. Cash flow improved significantly in 2025 with $1.33B net inflow, while debt remains elevated at $23.4B long-term.
Investment outlook balances high yield and dividend consistency against cigarette volume declines and regulatory risks. Analyst consensus remains bullish with a $67 price target, but ongoing litigation investigations and smoke-free transition execution pose significant challenges. The stock offers value at 13.7x P/E but requires careful monitoring of diversification efforts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Colgate-Palmolive Company
Since its founding in 1806, Colgate-Palmolive has grown to become a leading global consumer product company. In addition to its namesake oral care line, the firm manufactures shampoos, shower gels, deodorants, and home care products that are sold in over 200 countries (international sales account for about 70% of its consolidated total, including approximately 45% from emerging regions). It also owns specialty pet food maker Hill's, which sells its products through veterinarians and specialty pet retailers.
Read more on CL →About Altria Group Inc
Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).
Read more on MO →
